Jindong Li
No. 1 Jian She Rd
Zhengzhou, 450052, China
Zhengzhou, 450052, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Association of clinical response and lymph node yield with prognosis after neoadjuvant therapy for esophageal squamous cell carcinoma.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: May 13, 2026
Heterogeneity of adjuvant therapy effectiveness across post-neoadjuvant pathologic strata in esophageal squamous cell carcinoma: a retrospective cohort study.
Journal: Esophagus : official journal of the Japan Esophageal Society
Published: February 08, 2026
Lesion-level comparison of primary and secondary tumors after neoadjuvant immunochemotherapy in multifocal esophageal squamous cell carcinoma: a single-center retrospective study.
Journal: Journal of thoracic disease
Published: November 09, 2025
Comparative Efficacy and Safety of Neoadjuvant Immunochemotherapy Versus Chemotherapy in Locally Advanced Oesophageal Squamous Cell Carcinoma: A Dual-Centre Retrospective Study.
Journal: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
Published: March 27, 2025
Risk factors for unplanned intensive care unit admission after esophagectomy: a retrospective cohort study of 628 patients with esophageal cancer.
Journal: Frontiers in oncology
Published: June 03, 2024
Preoperative camrelizumab combined with chemotherapy for borderline resectable ESCC: A single-arm, prospective, phase 2 study.
Journal: Med (New York, N.Y.)
Published: March 01, 2024
Correction: Management of esophageal cancer in patients with a right aortic arch or double aortic arch: a case series of 34 cases.
Journal: Surgical endoscopy
Published: January 29, 2024
A 70-Year-Old Man With an Encapsulated Mediastinal Fluid Collection.
Journal: Chest
Published: January 05, 2024
Preoperative administration of camrelizumab combined with chemotherapy for borderline resectable esophageal squamous cell carcinoma (BRES-1): study protocol of a single-arm, open-label, phase II study.
Journal: Journal of thoracic disease
Published: December 05, 2023
Last Updated: 09/26/2026